Umfassende Service-Einschränkungen im Bereich Ausleihe ab 17. März!
ISO-690 (author-date, English)

FINKELMEIER, Fabian, 2021. Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Basel: Karger.

Elsevier - Harvard (with titles)

Finkelmeier, F., 2021. Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort, Liver cancer. Karger, Basel. https://doi.org/10.1159/000515490

American Psychological Association 7th edition

Finkelmeier, F. (ca. 2021). Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort [Cd]. In Liver cancer. Karger. https://doi.org/10.1159/000515490

Springer - Basic (author-date)

Finkelmeier F (2021) Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Karger, Basel

Juristische Zitierweise (Stüber) (Deutsch)

Finkelmeier, Fabian, Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort, Basel 2021.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.